明目逍遥颗粒防治原发性青光眼视神经损害的临床研究  被引量:3

Clinical study on prevention and treatment of optic nerve damage in primary glaucoma with Mingmu Xiaoyao Granule

在线阅读下载全文

作  者:张亿 桑子瑾[1] 胡佩 何宇鹏 武丹蕾[1] 张国亮[1] 张婷婷[1] 吴烈[1] ZHANG Yi;SANG Zijin;HU Pei;HE Yupeng;WU Danlei;ZHANG Guoliang;ZHANG Tingting;WU Lie(Guang´anmen Hospital,China Academy of Chinese Medical Sciences,Beijing 100053,China)

机构地区:[1]中国中医科学院广安门医院,北京100053

出  处:《中国中医眼科杂志》2023年第4期317-321,353,共6页China Journal of Chinese Ophthalmology

基  金:国家自然科学基金面上项目(81574030)。

摘  要:目的观察明目逍遥颗粒保护眼压控制稳定的原发性青光眼患者(肝郁血虚证)视神经的临床疗效。方法纳入2016年11月—2019年1月中国中医科学院广安门医院眼科诊治的肝郁血虚型原发性青光眼患者72例(144只眼),以随机数字表法分为试验组和对照组,每组各36例(72只眼)。试验组予明目逍遥颗粒口服,对照组予安慰剂口服。2组均治疗6个月。分别于治疗前、治疗后3个月和6个月检测受试者的视野平均缺损(MD)、晚期青光眼干预研究(AGIS)计分、P点个数、杯盘比(C/D)、最佳矫正视力(BCVA)、眼压和中医症候评分,并做统计分析。结果2组治疗前,以下各指标均无统计学意义(P>0.05)。(1)BCVA和眼压:治疗前后比较及治疗后组间比较,2组在BCVA和眼压方面均无统计学意义(P>0.05)。(2)视野指标:对照组治疗后MD较治疗前增加,差异有统计学意义(t=2.768,P=0.008)。治疗后2组间比较,试验组MD较对照组减少,差异有统计学意义(t=2.012,P=0.047)。试验组治疗后AGIS总分较治疗前减少,差异有统计学意义(t=2.114,P=0.039)。治疗后2组间比较,试验组AGIS总分较对照组减少,差异有统计学意义(t=2.010,P=0.047)。试验组治疗后P点总数较治疗前减少,差异有统计学意义(t=2.070,P=0.043);对照组治疗后P点总数较治疗前增加,差异有统计学意义(t=3.110,P=0.000)。治疗后2组间比较,试验组P点总数较对照组减少,差异有统计学意义(t=2.587,P=0.011)。(3)C/D:治疗前后比较及治疗后组间比较,2组在C/D方面均无统计学意义(P>0.05)。(4)中医症状积分:2组治疗后中医症状积分均较治疗前减少,差异均有统计学意义(t_(试验组)=6.169,P=0.000;t对照组=3.101,P=0.004)。治疗后2组间比较,试验组中医症状积分较对照组减少,差异有统计学意义(t=4.302,P=0.000)。结论明目逍遥颗粒可改善眼压控制稳定的原发性青光眼患者(肝郁血虚证)的视野敏感度,减少视野局部损害,有OBJECTIVE To observe the clinical effect of Mingmu Xiaoyao Granule on protecting the optic nerve of patients with primary glaucoma(liver depression and blood deficiency syndrome)with stable intraocular pressure(IOP)control.METHODS A total of 72 patients(144 eyes)with primary glaucoma of liver depression and blood deficiency syndrome who were diagnosed in the Department of Ophthalmology of Guang´anmen Hospital,China Academy of Chinese Medical Sciences from November 2016 to January 2019 were included in the study.They were divided into the experimental group(EG)and the control group(CG)by random number table method,with 36 patients(72 eyes)in each group.The experimental group was given Mingmu Xiaoyao Granules orally,and the control group was given placebo orally.Both groups were treated for six months.The mean visual field defect(MD),the scores of the Advanced Glaucoma Intervention Study(AGIS),the number of significant decline points in visual field sensitivity(P),the ratio of cup/disc(C/D),the best corrected visual acuity(BCVA),the IOP,and the scores of Traditional Chinese Medicine(TCM)symptoms were measured before the treatment,three and six months after the treatment.RESULTS Before the treatment,there was no significant difference in the following indexes between the two groups(P>0.05).(1)BCVA and IOP:There was no significant difference in BCVA and IOP between the two groups before and after the treatment(P>0.05).(2)Visual field indexes:The MD of the control group increased significantly after the treatment compared with that before the treatment(t=2.768,P=0.008).After the treatment,the MD of the experimental group decreased significantly when compared with that of the control group(t=2.012,P=0.047).The total scores of AGIS in the experimental group after the treatment was significantly lower than that before the treatment(t=2.114,P=0.039).The total number of P points in the experimental group after the treatment was significantly lower than that before the treatment(t=2.010,P=0.047).The total number of P point

关 键 词:疏肝养血 升阳通窍 明目逍遥颗粒 原发性青光眼 视神经损害 

分 类 号:R276.7[医药卫生—中医五官科学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象